---
title: "LifeMD to Report Second Quarter 2026 Financial Results on August 5 | LFMD Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293794080.md"
description: "LifeMD, Inc. (Nasdaq: LFMD) announced it will report its financial results for the second quarter and six months ended June 30, 2026, after market close on August 5, 2026. The company will host a conference call and webcast at 4:30 p.m. Eastern time to discuss these results."
datetime: "2026-07-24T12:05:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293794080.md)
  - [en](https://longbridge.com/en/news/293794080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293794080.md)
---

# LifeMD to Report Second Quarter 2026 Financial Results on August 5 | LFMD Stock News

See more from StockTitan in Google Search and AI answers.Adds StockTitan as a preferred source · opens Google

Add on Google

NEW YORK, July 24, 2026 (GLOBE NEWSWIRE) -- **LifeMD, Inc. (Nasdaq: LFMD)**, a leading provider of virtual primary care services, announces that it will report financial results for the three and six months ended June 30, 2026, after the close of the U.S. financial markets on August 5, 2026, and will host a conference call beginning at 4:30 p.m. Eastern time.

**Conference Call & Webcast Details**

Date:

Wednesday, August 5th

Time:

4:30 p.m. Eastern time

Toll-Free Dial-In:

(800) 715-9871

International Dial-In:

+1 (646) 307-1963

Conference ID:

3616168 (“LifeMD, Inc. Second Quarter 2026 Results”)

Live & Archived Webcast:

Link

Participants may also use the “Dial-Me In” option by visiting this link and entering their details.

**About LifeMD, Inc.**

LifeMD® is a leading provider of virtual primary care services. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.

**Investor Contact**  
ir@lifemd.com

**Media Contact**  
press@lifemd.com

### Related Stocks

- [LFMD.US](https://longbridge.com/en/quote/LFMD.US.md)
- [LFMDP.US](https://longbridge.com/en/quote/LFMDP.US.md)

## Related News & Research

- [LifeMD Reports Second Quarter 2026 Results | LFMD Stock News](https://longbridge.com/en/news/295008118.md)
- [LifeMD Q2 2026 earnings: GLP-1 transition widens losses despite margin gains](https://longbridge.com/en/news/295031758.md)
- [LFMD: Q2 2026 saw revenue of $47.3M, 89% gross margin, and 20% subscriber growth, with improved outlook](https://longbridge.com/en/news/295009065.md)
- [Vale updates financial events calendar for 2026](https://longbridge.com/en/news/294418484.md)
- [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md)